BU-NOT-SET

CONTACT US
One-year countdown to Brexit
  • Industry trends
Eyes
Insight
High throughput screening platform for liquid formulation design
  • Drug product
Man lab
White paper
Could limited access to the EU Hub threaten serialization readiness?
  • Manufacturing
Eyes
Insight
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
  • Drug product
Eyes
Insight
US DSCSA: data standardisation
  • Manufacturing
Eyes
Insight
Developments in high-throughput screening
  • Drug product
Eyes
Insight
CDMOs and innovation: remaining competitive
  • Industry trends
Eyes
Insight
2018 Forecast: What to watch out for over the coming 12 months in pharma
  • Industry trends
Eyes
Insight
Pharmaceutical Manufacturing: one year until the EU FMD
  • Manufacturing
Eyes
Insight
Insight
  • Drug product
Evolving strategies in oral solid dosage development
Case study
  • Sustainability
Sustainable pharmaceutical packaging
Webinar
  • Drug product
  • Manufacturing
Webinar | Bringing High Potent Drugs to Market
White paper
  • Drug product
  • Manufacturing
IVPT Strategies for reliable bioequivalence assessment
White paper
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing Optimizing TFF for RNA
Case study
  • Drug product
  • Manufacturing
Accelerating an innovative high potency oncology therapy to market
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes